Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCGR | P47871 | 14/20 | 0.55 |
| ▸ | GLP1R | P43220 | 2/20 | 0.51 |
| ▸ | GIPR | P48546 | 2/20 | 0.51 |
| ▸ | GCG | P01275 | 7/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21544912 | 1.00 | GCGR (0.55) | GCGRGLP1RGIPRGCG | |
| SCHEMBL21544989 | 1.00 | GCGR (0.55) | GCGRGLP1RGIPRGCG | |
| SCHEMBL21545051 | 0.95 | GCGR (0.61) | GCGRGLP1RGIPRGCG | |
| SCHEMBL21544886 | 0.92 | GCGR (0.50) | GCGRGLP1RGIPRGCG | |
| SCHEMBL21562711 | 0.90 | GCGR (0.45) | GCGRGLP1RGIPRGCG | |
| SCHEMBL21545043 | 0.90 | GCGR (0.45) | GCGRGLP1RGIPRGCG | |
| SCHEMBL21562708 | 0.90 | GCGR (0.45) | GCGRGLP1RGIPRGCG | |
| SCHEMBL21544906 | 0.89 | GCGR (0.59) | GCGRGLP1RGIPRGCG | |
| SCHEMBL21562702 | 0.89 | GCGR (0.59) | GCGRGLP1RGIPRGCG | |
| SCHEMBL21544961 | 0.88 | GCGR (0.59) | GCGRGCG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3573611-B1 | AMIDE COMPOUNDS AND USE THEREOF | ALPHALA CO LTD (TW) | 2022-01-12 | — | — | EP | claimed |
| US-10882837-B2 | Amide compounds and use thereof | ALPHALA CO., LTD. (TW) | 2021-01-05 | — | — | US | claimed |
| EP-3573611-B1 | AMIDE COMPOUNDS AND USE THEREOF | ALPHALA CO LTD (TW) | 2022-01-12 | — | — | EP | disclosed |
| EP-3573611-B1 | AMIDE COMPOUNDS AND USE THEREOF | ALPHALA CO LTD (TW) | 2022-01-12 | — | — | EP | disclosed |
| US-10882837-B2 | Amide compounds and use thereof | ALPHALA CO., LTD. (TW) | 2021-01-05 | — | — | US | disclosed |
| US-10882837-B2 | Amide compounds and use thereof | ALPHALA CO., LTD. (TW) | 2021-01-05 | — | — | US | disclosed |
| US-20190345118-A1 | AMIDE COMPOUNDS AND USE THEREOF | ALPHALA CO., LTD. (TW) | 2019-11-14 | — | — | US | disclosed |
| US-20190345118-A1 | AMIDE COMPOUNDS AND USE THEREOF | ALPHALA CO., LTD. (TW) | 2019-11-14 | — | — | US | disclosed |
| CN-110234318-A | Amide compound and its application | 昊运股份有限公司 | 2019-09-13 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10882837-B2 | Amide compounds and use thereof | GLP1R, IAPP, GCG | GCGR 5/4885GLP1R 1/4885GIPR 6/4885 |
| US-20190345118-A1 | AMIDE COMPOUNDS AND USE THEREOF | GLP1R, IAPP, GCG | GCGR 5/4885GLP1R 1/4885GIPR 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.